p3XFLAG-MKL2 Citations (3)

Originally described in: Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A, Prywes R J Biol Chem. 2003 Oct 24. 278(43):41977-87. PubMed Journal

---

Articles Citing p3XFLAG-MKL2

Articles
MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Alexander MS, Kawahara G, Motohashi N, Casar JC, Eisenberg I, Myers JA, Gasperini MJ, Estrella EA, Kho AT, Mitsuhashi S, Shapiro F, Kang PB, Kunkel LM. Cell Death Differ. 2013 Sep;20(9):1194-208. doi: 10.1038/cdd.2013.62. Epub 2013 Jun 14. PubMed
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Tello-Lafoz M, Srpan K, Sanchez EE, Hu J, Remsik J, Romin Y, Calo A, Hoen D, Bhanot U, Morris L, Boire A, Hsu KC, Massague J, Huse M, Er EE. Immunity. 2021 May 11;54(5):1037-1054.e7. doi: 10.1016/j.immuni.2021.02.020. Epub 2021 Mar 22. PubMed
Regulation of the Muscarinic M3 Receptor by Myocardin-Related Transcription Factors. Liu L, Rippe C, Hansson O, Kryvokhyzha D, Fisher S, Ekman M, Sward K. Front Physiol. 2021 Sep 3;12:710968. doi: 10.3389/fphys.2021.710968. eCollection 2021. PubMed

If you have published an article using this material, please email us at to have your article added to this page.